… on the pathophysiological implications of glycosylation. Fortunately, cutting-edge …
cancer-related glycosylation. Thus, glycans as well as aberrantly glycosylated protein-based cancer …

… Aberrant glycosylation is often cited as a ‘hallmark of cancer’ … than aberrant glycosylation
being itself a hallmark of cancer, … that glycans play a role in every recognised cancer hallmark. …

Glycosylation alterations are involved in several steps of human cancer pathogenesis. In this
issue of Cancer Cell, Agrawal et al. identified the glycosyltransferase FUT8 as a previously …

… of cancer biomarker discovery using aberrant glycosylation in three areas. First, changes in
glycosylation machinery such as glycosyltransferases/glycosidases could be used as cancer …

… cancer biomarkers. In particular, we will focus on the aberrant CD43 glycosylation as cancer
… to exploit the UN1 monoclonal antibody (UN1 mAb) to identify aberrant CD43 glycoforms. …

… Furthermore, such aberrant glycan structures play key roles in the acquisition of molecular
… anti-cancer targeted agents. In this review, we highlight the impact of glycosylation in cancer …

… in cancer. We see how different epigenetic mechanisms converge to regulate specific pathways
of cancer-… We also summarize the case of O-linked GlcNAc, in which glycosylation is not …

… cancer … glycosylation machinery is associated with cancer progression and metastasis. We
also provide insights into the influence of aberrant glycosylation in the development of cancer …

… remarkable progress in cancer research, … Aberrant glycosylation interferes with regulation
of cell adhesion, migration and proliferation. Glycosylation may represent a hallmark of cancer, …

… of cancer cells. The most-widely occurring changes in glycosylation associated with cancer
… Aberrant glycosylation in cancer frequently involves an increase in sialyl Lewis x (SLe x ) …